SGLT2 inhibition in cardiology: what a cardiologist needs to know.
Topic:
Diabetes, dysglycaemia and metabolic syndrome
Speaker:
Professor N. Sattar (Glasgow, GB)
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly
Event:
ESC Congress 2017
Congress Presentation
About the speaker
Professor Naveed Sattar
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
42
presentations
2
followers
2 more presentations in this session
Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.
Speaker: Professor J. Deanfield (London, GB)
Panel discussion; SGLT2 in clinical cardiology.
Speaker: Professor S. Anker (Berlin, DE) Professor N. Sattar (Glasgow, GB) Professor J. Deanfield (London, GB) Doctor D. Fitchett (Toronto, CA)
Access the full session
Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Speakers:
Professor N. Sattar, Professor J. Deanfield, Professor S. Anker, Professor N. Sattar, Professor J. Deanfield...
About the event
ESC 365 is supported by
